Cambridge Investment Research Advisors, Inc. Senseonics Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 37,174 shares of SENS stock, worth $25,278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,174
Previous 26,274
41.49%
Holding current value
$25,278
Previous $9,000
111.11%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SENS
# of Institutions
138Shares Held
80.6MCall Options Held
418KPut Options Held
219K-
Vanguard Group Inc Valley Forge, PA22.2MShares$15.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$5.66 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$4.76 Million0.14% of portfolio
-
First Light Asset Management, LLC Edina, MN6.43MShares$4.37 Million0.33% of portfolio
-
Geode Capital Management, LLC Boston, MA6.41MShares$4.36 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $317M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...